Search research articles
Contact Us
Filters
Showing results (51-60 of 55) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 55 results.
Communications Biology
|
May 4, 2024
Personalized whole-brain neural mass models reveal combined Aβ and tau hyperexcitable influences in Alzheimer's disease
Lazaro M Sanchez-Rodriguez, Gleb Bezgin, Felix Carbonell, et al.
Biorxiv : the Preprint Server for Biology
|
July 28, 2023
Revealing the combined roles of Aβ and tau in Alzheimer's disease via a pathophysiological activity decoder
Lazaro M Sanchez-Rodriguez, Gleb Bezgin, Felix Carbonell, et al.
British Journal of Haematology
|
January 10, 2012
Chronic lymphocytic leukaemia with 17p deletion: a retrospective analysis of prognostic factors and therapy results
Julio Delgado, Blanca Espinet, Ana C Oliveira, et al.
Blood
|
October 15, 2013
Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia
Pau Abrisqueta, Neus Villamor, María José Terol, et al.
Haematologica
|
November 27, 2010
Cytogenetic risk stratification in chronic myelomonocytic leukemia
Esperanza Such, José Cervera, Dolors Costa, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 55) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 55 results.
Communications Biology
|
May 4, 2024
Personalized whole-brain neural mass models reveal combined Aβ and tau hyperexcitable influences in Alzheimer's disease
Lazaro M Sanchez-Rodriguez, Gleb Bezgin, Felix Carbonell, et al.
Biorxiv : the Preprint Server for Biology
|
July 28, 2023
Revealing the combined roles of Aβ and tau in Alzheimer's disease via a pathophysiological activity decoder
Lazaro M Sanchez-Rodriguez, Gleb Bezgin, Felix Carbonell, et al.
British Journal of Haematology
|
January 10, 2012
Chronic lymphocytic leukaemia with 17p deletion: a retrospective analysis of prognostic factors and therapy results
Julio Delgado, Blanca Espinet, Ana C Oliveira, et al.
Blood
|
October 15, 2013
Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia
Pau Abrisqueta, Neus Villamor, María José Terol, et al.
Haematologica
|
November 27, 2010
Cytogenetic risk stratification in chronic myelomonocytic leukemia
Esperanza Such, José Cervera, Dolors Costa, et al.
Page
of 6